MOSCOW, April 3 – RIA Novosti. Not all test systems can detect antibodies to coronavirus infection after vaccination with EpiVacKorona, special tests that can determine immunity after vaccination are supplied to all regions where they are vaccinated with this vaccine, Rospotrebnadzor reported.
According to the data on the website of the federal service, most tests detect a wide range of antibodies to various regions of the S envelope protein of the coronavirus, and their sensitivity may not be sufficient to detect a small pool of key antibodies that are formed after vaccination with EpiVacCorona. The spread of the coronavirus
“Such test systems with a high probability will not detect antibodies in persons vaccinated with EpiVacCorona … To assess the level of immunity formed after vaccine administration, it is necessary to use special ELISA test systems” SARS-CoV-2-IgG-Vector “.. These … test kits are supplied to all regions where the population is immunized with the EpiVacCorona vaccine, the website of the federal service says.
As noted on the Rospotrebnadzor website, after vaccination with EpiVacKorona, antibodies are induced against the regions of the envelope protein S that are functionally important in the life cycle of the virus. At the same time, the immune system is not burdened by the production of antibodies that play a lesser role in the fight against the virus.